Process for the recovery of beta acetylfuranoside

US9580455B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9580455-B2
Application numberUS-201213675220-A
CountryUS
Kind codeB2
Filing dateNov 13, 2012
Priority dateJan 27, 2009
Publication dateFeb 28, 2017
Grant dateFeb 28, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

There is provided an improved method for the recovery of residual, unseparated β-acetylfuranoside from reaction mixtures remaining from an initial synthesis of acetylfuranoside, which is in particular usable on a large industrial scale, more particularly in the production of capecitabine.

First claim

Opening claim text (preview).

What is claimed: 1. A method for recovery of initially not separated β-acetylfuranoside from mother liquor remaining from the synthesis of acetylfuranoside (ACF), comprising the following sequential steps: a) Evaporation to less than 1% residual solvent of the mother liquor remaining from an initial synthesis of ACF, to increase the content of residual α/β-ACF from about 8 to 15 weight-% to about 25 to 45 weight-%, followed by distillation to about 60 to 80 weight- and subsequent crystallization of β-ACF out of the distillate by adding a suitable solvent; b) Chemical conversion of α/β-ACF mixture remaining in the mother liquor of step a), to β-ACF by de-acetylation and subsequent re-acetylation, followed by crystallization of β-ACF by addition of a suitable solvent; c) Optional repetition of step a) and b) in a sequential (clockwise) cyclic process; wherein the distillation to about 60 to 80 weight-% of step a) is carried out at 1 to 3 mbar and 200 to 210° C. heating temperature in a continuous thin film evaporator. 2. The process according to claim 1 , wherein step b) comprises the de-acetylation of α/β-ACF in the presence of a suitable base, followed by neutralization with a suitable acid and further followed by the re-acetylation reaction in the presence of suitable base, a suitable catalyst and a suitable acetylating agent.

Assignees

Inventors

Classifications

  • C07H13/04Primary

    having the esterifying carboxyl radicals attached to acyclic carbon atoms · CPC title

  • C07H1/00Primary

    Processes for the preparation of sugar derivatives · CPC title

  • Separation; Purification · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9580455B2 cover?
There is provided an improved method for the recovery of residual, unseparated β-acetylfuranoside from reaction mixtures remaining from an initial synthesis of acetylfuranoside, which is in particular usable on a large industrial scale, more particularly in the production of capecitabine.
Who is the assignee on this patent?
Hoffmann La Roche
What technology area does this patent fall under?
Primary CPC classification C07H13/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).